BCR::ABL1, JAK2, and STAT5A are all involved in progression of CML. Even if one pathway is suppressed, leukemic cells can still proliferate through other signaling pathways. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.